Capture of cell culture-derived influenza virus by lectins: Strain independent, but host cell dependent

Journal of Virological Methods

Volumn 154, Issue 1-2, 2008, Pages 61-68

  Opitz, Lars ^a   Zimmermann, Anke ^a   Lehmann, Sylvia ^a   Genzel, Yvonne ^a   Lübben, Holger ^b   Reichl, Udo ^a,c   Wolff, Michael W ^a,c  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b Novartis Behring   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Euonymus europaeus lectin; Influenza virus; Lectin affinity chromatography; Vaccine purification

Indexed keywords

LECTIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EUONYMUS; GLYCOSYLATION; INFLUENZA VIRUS; LECTIN BINDING; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; VIRUS ATTACHMENT; VIRUS STRAIN;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; PLANT LECTINS; PROTEIN BINDING; SURFACE PLASMON RESONANCE;

EUONYMUS EUROPAEUS; ORTHOMYXOVIRIDAE;

EID: 56249102761     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.09.004     Document Type: Article

References (35)

1. Alymova I.V., Kodihalli S., Govorkova E.A., Fanget B., Gerdil C., and Webster R.G. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. Journal of Virology 72 (1998) 4472-4477
2. Anonym. Heparin as pseudo affinity chromatography ligand in influenza virus purification. IP. com Journal 6 (2006) 2
3. Bardiya N., and Bae J.H. Influenza vaccines: recent advances in production technologies. Applied Microbiology & Biotechnology 67 (2005) 299-305
4. Basak S., Pritchard D.G., Bhown A.S., and Compans R.W. Glycosylation sites of influenza viral glycoproteins: characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein. Journal of Virology 37 (1981) 549-558
5. Brands R., Visser J., Medema J., Palache A.M., and van Scharrenburg G.J.M. Inlfuvac: a safe Madin Darby canine kidney (MDCK) cell culture-based influenza vaccine. Developments in Biological Standardization 98 (1999) 93-100
6. Bruhl P., Kerschbaum A., Kistner O., Barrett N., Dorner F., and Gerencer M. Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine. Vaccine 19 (2000) 1149-1158
7. Deom C.M., and Schulze I.T. Oligosaccharide composition of an influenza virus hemagglutinin with host-determined binding properties. The Journal of Biological Chemistry 260 (1985) 14771-14774
8. Genzel Y., Behrendt I., Konig S., Sann H., and Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22 (2004) 2202-2208
9. Geyer H., Kempf R., Schott H.-H., and Geyer R. Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells. European Journal of Biochemistry 193 (1990) 855-862
10. Govorkova E.A., Murti G., Meignier B., de Taisne C., and Webster R.G. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. Journal of Virology 70 (1996) 5519-5524
11. Hsieh P., Rosner M.R., and Robbins P.W. Host-dependent variation of asparagine-linked oligosaccharides at individual glycosylation sites of Sindbis virus glycoproteins. The Journal of Biological Chemistry 258 (1983) 2548-2554
12. Kalbfuß B., Genzel Y., Wolff M., Zimmermann A., Morenweiser R., and Reichl U. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and Bioengineering 97 (2007) 73-85
13. Kalbfuß B., Knochlein A., Krober T., and Reichl U. Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 36 (2008) 145-161
14. Kalbfuß B., Wolff M., Morenweiser R., and Reichl U. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnology and Bioengineering 96 (2007) 932-944
15. Kang K.A., and Ryu D.D.Y. Studies on scale-up parameters of an immunoglobulin separation system using protein A affinity chromatography. Biotechnology Progress 7 (1991) 205-212
16. Karlsson R., Michaelsson A., and Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. Journal of Immunological Methods 145 (1991) 229-240
17. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., and Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16 (1998) 960-968
18. Kristiansen T., Sparrman M., and Heller L. Towards a subunit influenza vaccine prepared by affinity chromatography on immobilized lectin. Journal of Biosciences 5 (1983) 149-155
19. Lauffenburger D.A., and Linderman J.J. Receptors: Models for Binding, Trafficking and Signaling (1993), Oxford University Press, New York, Oxford
20. Liedtke S., Adamski M., Geyer R., Pfutzner A., Rubsamen-Waigmann H., and Geyer H. Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. Glycobiology 4 (1994) 477-484
21. Malmqvist M. Biospecific interaction analysis using biosensor technology. Nature 361 (1993) 186-187
22. Mir-Shekari S.Y., Ashford D.A., Harvey D.J., Dwek R.A., and Schulze I.T. The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. The Journal of Biological Chemistry 272 (1997) 4027-4036
23. Opitz L., Lehmann S., Zimmermann A., Reichl U., and Wolff M.W. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. Journal of Biotechnology 131 (2007) 309-317
24. Opitz L., Salaklang J., Büttner H., Reichl U., and Wolff M.W. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine 25 (2007) 939-947
25. Palache A.M., Brands R., and van Scharrenburg G.J.M. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. The Journal of Infectious Diseases 176 (1997) S20-S24
26. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., and Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19 (2001) 2716-2721
27. Schulze I.T. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. The Journal of Infectious Diseases 176 (1997) s24-28
28. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., and Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19 (2001) 3444-3450
29. Van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carstens, E.B., Estes, M.K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle, C.R., Wickner, R.B., 2000. Virus Taxonomy: seventh report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego.
30. Van Scharrenburg, G.J.M., Brands, R., 1998. Influenza vaccine. European Patent Office 0 870 508 B1.
31. Werner R.G., Kopp K., and Schlueter M. Glycosylation of therapeutic proteins in different production systems. Acta Paediatrica 96 (2007) 17-22
32. WHO, 2007. Projected supply of pandemic influenza vaccine sharply increases, http://www.who.int/mediacentre/news/releases/2007/pr60/en/index.html; 2008/07/31, Geneva.
33. Wickramasinghe S.R., Kalbfuß B., Zimmermann A., Thom V., and Reichl U. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnology and Bioengineering 92 (2005) 199-208
34. Wilson I.A., Skehel J.J., and Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 [angst] resolution. Nature 289 (1981) 366-373
35. Wood J.M., Schild G.C., Newman R.W., and Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines. Journal of Biological Standardization 5 (1977) 237-247